Evidence map›Paper›PMID 31983181›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2020

Stenting in Non-Small Cell Lung Cancer: How Does It Affect the Outcomes?

Nagla Abdel Karim, Sinan Khaddasn, Mahmoud Shehata, Ahmed Mostafa, Mohamed Magdy, Ihab Eldessouki, Changchun Xie, Sadia Benzequene

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nagla Abdel KarimHematology-Oncology Department Augusta University, U S A.
Sinan KhaddasnHematology-Oncology Department, Vontz Center, University of Cincinnati, Ohio, U S A.
Mahmoud ShehataHematology-Oncology Department, Vontz Center, University of Cincinnati, Ohio, U S A.
Ahmed MostafaHematology-Oncology Department, Vontz Center, University of Cincinnati, Ohio, U S A.
Mohamed MagdyHematology-Oncology Department Augusta University, U S A.
Ihab EldessoukiHematology-Oncology Department, Vontz Center, University of Cincinnati, Ohio, U S A.
Changchun XieHematology-Oncology Department, Vontz Center, University of Cincinnati, Ohio, U S A.
Sadia BenzequeneHematology-Oncology Department, Vontz Center, University of Cincinnati, Ohio, U S A.
University of Cincinnati · USAugusta University Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveApproximately 30% of lung cancer patients develop central airway obstruction (CAO) that remarkably shortens survival. There is little data about the benefits of stenting within this heterogeneous patient group. Our objective was to review their overall survival (OS) and their risk of hospitalization versus patients who did not have lesions requiring stent placement.

methodsWe retrospectively reviewed charts of 171 non-small cell lung cancer (NSCLC) patients who underwent bronchoscopy in the University of Cincinnati Cancer Center from the year 2011 to 2013. Twenty-five patients with advanced lung cancer were evaluated by interventional pulmonology service for endobronchial stent placement for CAO. Eight patients did not require placement of a stent and 17 had obstructive lesions that required stenting by interventional pulmonology.

resultsDemographical parameters such as age and gender did not have a significant impact on the risk of hospitalization or OS of both groups of patients, however, those whose lesions did not mandate stent placement had significantly lower odds of hospitalization compared to patients with CAO requiring a stent (OR: 15.913, 95% CI: 1.211-209.068, P = 0.0352). Patients with advanced NSCLC and CAO that required stent placement had an OS of 13.9 m [3.9-19.9 m] compared to an OS of 23.9 m for patients with CAO not requiring a stent. We found out that patients with less severe CAO have lower odds of hospitalization and better OS compared to patients with CAO mandating stent placement.

conclusionCAO patients with interventional pulmonology (IP) evaluation and management in addition, may have improved OS suggesting that IP consultation might offer both improvement in quality of life and overall survival to patients with advanced NSCLC and CAO. <br />.

Indexed as

Quality of LifeAirway ObstructionBronchoscopyCarcinoma, Non-Small-Cell LungCase-Control StudiesFollow-Up StudiesHumansLung NeoplasmsRetrospective StudiesStentsSurvival RateTreatment OutcomeCentral Airway ObstructionLung cancernon-small cell lung cancerStenting

Identifiers

PMID31983181
PMCPMC7294028
OpenAlexW3003962076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.